Caffeine Supplementation Has No Effect on Dribbling Speed in Elite Basketball Players.


Journal

International journal of sports physiology and performance
ISSN: 1555-0273
Titre abrégé: Int J Sports Physiol Perform
Pays: United States
ID NLM: 101276430

Informations de publication

Date de publication:
01 07 2019
Historique:
aheadofprint: 20 12 2018
entrez: 21 12 2018
pubmed: 21 12 2018
medline: 18 10 2019
Statut: epublish

Résumé

To examine the effect of caffeine supplementation on dribbling speed in elite female and male basketball players. A double-blind, counterbalanced, randomized, crossover design was utilized. Elite basketball players (n = 21; female, n = 10; male, n = 11; age = 18.3 ± 3.3 yr) completed placebo (3 mg·kg-1 of body mass of dextrose) and caffeine (3 mg·kg-1 of body mass) trials 1 week apart during the in-season phase. During each trial, players completed 20-m linear sprints with and without dribbling a basketball. Performance times were recorded at 5-m, 10-m, and 20-m splits. Dribbling speed was measured using traditional (total performance time) and novel (Dribble Deficit) methods. Dribble Deficit isolates the added time taken to complete a task when dribbling compared to a non-dribbling version of the same task. Comparisons between placebo and caffeine conditions were conducted at group and individual levels. Non-significant (P > 0.05), trivial-small (effect size = 0.04-0.42) differences in dribbling speed were observed between conditions. The majority (20 out of 21) of players were classified as non-responders to caffeine, with 1 player identified as a negative responder using Dribble Deficit measures. Results indicate caffeine offers no ergogenic benefit to dribbling speed in elite basketball players. The negative response to caffeine in one player indicates caffeine supplementation may be detrimental to dribbling speed in specific cases and emphasizes the need for individualized analyses in nutrition-based sport science research.

Identifiants

pubmed: 30569790
doi: 10.1123/ijspp.2018-0871
pii: ijspp.2018-0871
doi:
pii:

Substances chimiques

Performance-Enhancing Substances 0
Caffeine 3G6A5W338E

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

997-1000

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH